Imanova logo

Imanova is a translational research company that specialises in applying positron emission tomography (PET) and magnetic resonance imaging (MRI) scanning techniques to improve productivity in early drug development and to help improve disease understanding.

Established in 2011 Imanova was formed in an innovative alliance between the UK's Medical Research Council, Imperial College London, King's College London and University College London to act as a conduit between academia and industry.

Since inception, Imanova has completed over 50 clinical studies and is in a unique position to facilitate productive, mutually beneficial relationships between academia and industry.

Contact Imanova via their website

News archive

10/11/2016   Imanova Study featured in SNMMI newsletter...more
04/11/2016   Imanova Article: Advanced Translational Imaging For CNS Drug Development...more
24/10/2016   Imanova Forms Pre-Competitive Consortium - MIND MAPS...more
14/09/2016   Imanova among 5 Scrip Awards’ finalists...more
14/09/2016   New Ligands Available At Imanova...more
31/08/2016   Study Conducted at Imanova Evaluates MS Link With Depression...more
31/08/2016   Gut Hormones in Addiction (GHADD) Study to Take Place at Imanova...more
31/08/2016   PET/MRI machine Installed at Imanova...more
22/08/2016   Imanova Plays Central Role in Global Alzheimer’s Detection Study...more
28/07/2016   Imanova Collaboration Characterises Radio-Tracer...more
21/07/2016   Imanova Announces Validation of New SV2A Radioligand for CNS...more
12/07/2016   Imanova Takes Delivery of Medical Research Council (MRC) Funded PET-MRI Scanner...more
31/03/2016   Imanova joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code